Provided by Tiger Trade Technology Pte. Ltd.

Denali Therapeutics Inc.

18.42
-0.7400-3.86%
Volume:319.63K
Turnover:5.93M
Market Cap:2.94B
PE:-6.50
High:19.04
Open:19.04
Low:18.36
Close:19.16
52wk High:27.30
52wk Low:13.75
Shares:159.85M
Float Shares:151.07M
Volume Ratio:0.49
T/O Rate:0.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8353
EPS(LYR):-2.9700
ROE:-54.93%
ROA:-29.15%
PB:3.53
PE(LYR):-6.20

Loading ...

Jun 28, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 20, 2023

Major Issues Report

Form 8-K - Current report
Jun 16, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 05, 2023

Major Issues Report

Form 8-K - Current report
Jun 03, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 08, 2023

Major Issues Report

8-K - Current report
May 08, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 20, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 30, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 27, 2023

Major Issues Report

8-K - Current report
Feb 27, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 09, 2023

Major Issues Report

8-K - Current report
Nov 03, 2022

Major Issues Report

8-K - Current report
Nov 03, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 20, 2022

Major Issues Report

8-K - Current report
Oct 18, 2022

Major Issues Report

8-K - Current report